Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.

Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, Shen F, Wu MC.

Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.

PMID:
22621971
2.

Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.

Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y.

World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249. Review.

3.

Hepatitis B viral load affects prognosis of hepatocellular carcinoma.

Yu SJ, Kim YJ.

World J Gastroenterol. 2014 Sep 14;20(34):12039-44. doi: 10.3748/wjg.v20.i34.12039. Review.

4.

Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis.

Zhou Y, Zhang Z, Zhao Y, Wu L, Li B.

World J Surg. 2014 Sep;38(9):2395-402. doi: 10.1007/s00268-014-2586-z. Review.

PMID:
24791945
5.

Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.

Wei Q, Xu X, Ling Q, Zhou B, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):251-5. Review.

6.

Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.

Xu J, Li J, Chen J, Liu ZJ.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):331-40. doi: 10.17219/acem/29760. Review.

7.

Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?

Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ.

Ann Surg Oncol. 2014 Mar;21(3):1010-5. Review.

PMID:
24121884
8.

Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.

Chong CC, Wong GL, Lai PB.

World J Gastroenterol. 2014 May 28;20(20):6006-12. doi: 10.3748/wjg.v20.i20.6006. Review.

9.

Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.

Ishikawa T.

World J Gastroenterol. 2013 Dec 21;19(47):8861-6. doi: 10.3748/wjg.v19.i47.8861. Review.

10.

Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.

Zhou HY, Luo Y, Chen WD, Gong GZ.

J Gastroenterol Hepatol. 2015 Jun;30(6):977-83. doi: 10.1111/jgh.12917. Review.

PMID:
25689418
11.

Postoperative therapy options for hepatocellular carcinoma.

Zhong JH, Ma L, Li LQ.

Scand J Gastroenterol. 2014 Jun;49(6):649-61. doi: 10.3109/00365521.2014.905626. Epub 2014 Apr 10. Review.

PMID:
24716523
12.

How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?

Wang CC, Kao JH.

Expert Opin Pharmacother. 2016;17(7):911-9. doi: 10.1517/14656566.2016.1149165. Epub 2016 Feb 25. Review.

PMID:
26831361
13.

Role of antiviral therapy in the management of hepatocellular carcinoma.

Guan YS, He Q.

Anticancer Drugs. 2013 Apr;24(4):337-43. doi: 10.1097/CAD.0b013e32835ec39a. Review.

PMID:
23388161
14.

Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.

Zhang YQ, Guo JS.

World J Gastroenterol. 2015 Apr 7;21(13):3860-6. doi: 10.3748/wjg.v21.i13.3860. Review.

15.

Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis.

Yuan P, Chen P, Qian Y.

Can J Gastroenterol Hepatol. 2016;2016:5234969. doi: 10.1155/2016/5234969. Epub 2016 Mar 10. Review.

16.

Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis.

Sun P, Dong X, Cheng X, Hu Q, Zheng Q.

PLoS One. 2014 Jul 24;9(7):e102761. doi: 10.1371/journal.pone.0102761. eCollection 2014. Review.

17.

Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Chau GY.

World J Gastroenterol. 2014 Sep 21;20(35):12473-84. doi: 10.3748/wjg.v20.i35.12473. Review.

18.

Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis.

Xia BW, Zhang YC, Wang J, Ding FH, He XD.

Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):458-68. doi: 10.1016/j.clinre.2014.12.003. Epub 2015 Jan 28. Review.

PMID:
25650304
19.

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies.

Zhou Y, Si X, Wu L, Su X, Li B, Zhang Z.

World J Surg Oncol. 2011 Sep 21;9:108. doi: 10.1186/1477-7819-9-108. Review.

20.

Recent advances in the prevention of hepatocellular carcinoma recurrence.

Lu LC, Cheng AL, Poon RT.

Semin Liver Dis. 2014 Nov;34(4):427-34. doi: 10.1055/s-0034-1394141. Epub 2014 Nov 4. Review.

PMID:
25369304

Supplemental Content

Support Center